ProShare Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$305M Sell
1,247,708
-155,070
-11% -$36.1M 0.45% 27
2025
Q4
$290M Sell
1,402,778
-110,041
-7% -$21.8M 0.51% 33
2025
Q3
$281M Sell
1,512,819
-53,788
-3% -$9.22M 0.59% 20
2025
Q2
$239M Sell
1,566,607
-98,924
-6% -$15.2M 0.48% 35
2025
Q1
$276M Sell
1,665,531
-5,710
-0.3% -$893K 0.62% 24
2024
Q4
$242M Buy
1,671,241
+102,597
+7% +$15.9M 0.55% 31
2024
Q3
$254M Sell
1,568,644
-83,089
-5% -$13.2M 0.62% 28
2024
Q2
$241M Buy
1,651,733
+147,609
+10% +$22M 0.65% 24
2024
Q1
$238M Sell
1,504,124
-19,340
-1% -$3.08M 0.63% 28
2023
Q4
$239M Buy
1,523,464
+34,441
+2% +$5.28M 0.73% 20
2023
Q3
$232M Sell
1,489,023
-139,829
-9% -$23.1M 0.72% 20
2023
Q2
$270M Buy
1,628,852
+29,046
+2% +$4.69M 0.78% 11
2023
Q1
$248M Buy
1,599,806
+105,743
+7% +$17.1M 0.76% 15
2022
Q4
$264M Buy
1,494,063
+47,848
+3% +$8.26M 0.93% 9
2022
Q3
$236M Sell
1,446,215
-40,329
-3% -$6.82M 0.91% 11
2022
Q2
$264M Sell
1,486,544
-260,701
-15% -$46.4M 0.88% 10
2022
Q1
$310M Buy
1,747,245
+24,086
+1% +$4.1M 0.67% 21
2021
Q4
$295M Buy
1,723,159
+246,180
+17% +$40.3M 0.58% 26
2021
Q3
$239M Buy
1,476,979
+14,065
+1% +$2.4M 0.67% 19
2021
Q2
$241M Buy
1,462,914
+190,872
+15% +$31.6M 0.7% 17
2021
Q1
$209M Buy
1,272,042
+39,311
+3% +$6.36M 0.66% 20
2020
Q4
$194M Buy
1,232,731
+89,803
+8% +$13.3M 0.72% 17
2020
Q3
$170M Buy
1,142,928
+68,753
+6% +$10.2M 0.79% 16
2020
Q2
$151M Sell
1,074,175
-89,021
-8% -$13M 0.81% 12
2020
Q1
$153M Sell
1,163,196
-361,212
-24% -$51.2M 1.1% 9
2019
Q4
$222M Buy
1,524,408
+240,999
+19% +$32.7M 1.03% 9
2019
Q3
$166M Buy
1,283,409
+146,614
+13% +$19.3M 0.93% 10
2019
Q2
$158M Sell
1,136,795
-79,213
-7% -$11M 0.95% 10
2019
Q1
$170M Buy
1,216,008
+73,448
+6% +$9.84M 1.02% 10
2018
Q4
$147M Buy
1,142,560
+77,627
+7% +$10.8M 1.03% 10
2018
Q3
$147M Sell
1,064,933
-103,593
-9% -$13.8M 1% 9
2018
Q2
$142M Sell
1,168,526
-54,799
-4% -$6.84M 0.95% 10
2018
Q1
$157M Buy
1,223,325
+72,166
+6% +$9.75M 1.02% 9
2017
Q4
$161M Buy
1,151,159
+263,287
+30% +$36.7M 1.12% 8
2017
Q3
$115M Buy
887,872
+21,963
+3% +$2.91M 1.06% 9
2017
Q2
$115M Sell
865,909
-60,204
-7% -$7.68M 1.14% 8
2017
Q1
$115M Buy
926,113
+41,737
+5% +$4.99M 1.21% 6
2016
Q4
$102M Buy
884,376
+145,270
+20% +$16.8M 1.13% 6
2016
Q3
$87.3M Sell
739,106
-83,584
-10% -$10.1M 1.22% 6
2016
Q2
$99.8M Buy
822,690
+65,793
+9% +$7.48M 1.29% 6
2016
Q1
$81.9M Sell
756,897
-106,801
-12% -$11.1M 1.13% 9
2015
Q4
$88.7M Buy
863,698
+49,088
+6% +$4.94M 1.07% 13
2015
Q3
$76M Buy
814,610
+48,108
+6% +$4.65M 1.07% 12
2015
Q2
$74.7M Sell
766,502
-93,339
-11% -$9.35M 1.03% 12
2015
Q1
$86.5M Sell
859,841
-14,385
-2% -$1.46M 1.02% 11
2014
Q4
$91.4M Buy
874,226
+194,823
+29% +$20.5M 1.06% 11
2014
Q3
$72.4M Sell
679,403
-40,881
-6% -$4.24M 0.96% 10
2014
Q2
$75.4M Sell
720,284
-9,840
-1% -$995K 0.98% 9
2014
Q1
$71.7M Buy
730,124
+56,195
+8% +$5.21M 0.9% 9
2013
Q4
$61.7M Buy
673,929
+312,807
+87% +$28.8M 0.92% 12
2013
Q3
$31.3M Sell
361,122
-212,755
-37% -$19.1M 0.74% 14
2013
Q2
$49.3M Buy
+573,877
New +$48.7M 0.97% 11

Other funds holding JNJ

ProShare Advisors's JNJ Position: Q1 2026 in Review

ProShare Advisors reduced its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, selling an estimated $36.1M and leaving 1,247,708 shares worth $305M. The position accounts for 0.45% of the portfolio, ranked #27.

ProShare Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $310M in Q1 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • ProShare Advisors held 1,247,708 shares of Johnson & Johnson worth $305M as of Q1 2026.
  • ProShare Advisors sold 155,070 Johnson & Johnson shares in Q1 2026, an estimated $36.1M.
  • Johnson & Johnson made up 0.45% of ProShare Advisors's portfolio in Q1 2026, its #27 holding.
  • ProShare Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • ProShare Advisors's Johnson & Johnson position peaked at $310M in Q1 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.